{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:03:49Z","timestamp":1771333429550,"version":"3.50.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05740-z","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:23:05Z","timestamp":1771323785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Transcriptomic Analysis Identifies Novel Mitochondrial Gene Targets in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Anusree","family":"Damodaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanskriti","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"8","key":"5740_CR1","first-page":"504","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd G, Philip A (2015) Parkinson\u2019s disease and its management: Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40(8):504\u2013532","journal-title":"P T"},{"issue":"7","key":"5740_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s disease and parkinsonism. Am J Med 132(7):802\u2013807","journal-title":"Am J Med"},{"key":"5740_CR3","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952","journal-title":"BMJ"},{"issue":"5","key":"5740_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11011-021-00689-5","volume":"36","author":"V Zaman","year":"2021","unstructured":"Zaman V et al (2021) Cellular and molecular pathophysiology in the progression of Parkinson\u2019s disease. Metab Brain Dis 36(5):815\u2013827","journal-title":"Metab Brain Dis"},{"issue":"2","key":"5740_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14728214.2020.1763954","volume":"25","author":"S AlShimemeri","year":"2020","unstructured":"AlShimemeri S, Fox SH, Visanji NP (2020) Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update. Expert Opin Emerg Drugs 25(2):131\u2013144","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"5740_CR6","doi-asserted-by":"publisher","first-page":"19272","DOI":"10.1038\/s41598-023-44142-2","volume":"13","author":"H Asano","year":"2023","unstructured":"Asano H et al (2023) Safety comparisons among monoamine oxidase inhibitors against Parkinson\u2019s disease using FDA adverse event reporting system. Sci Rep 13(1):19272","journal-title":"Sci Rep"},{"issue":"3","key":"5740_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","volume":"20","author":"S Pandey","year":"2017","unstructured":"Pandey S, Srivanitchapoom P (2017) Levodopa-induced dyskinesia: clinical features, pathophysiology, and medical management. Ann Indian Acad Neurol 20(3):190\u2013198","journal-title":"Ann Indian Acad Neurol"},{"issue":"7","key":"5740_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH et al (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22(7):1099\u20131109","journal-title":"Nat Neurosci"},{"key":"5740_CR9","doi-asserted-by":"publisher","first-page":"1219441","DOI":"10.3389\/fnins.2023.1219441","volume":"17","author":"MM Harraz","year":"2023","unstructured":"Harraz MM (2023) Selective dopaminergic vulnerability in Parkinson\u2019s disease: new insights into the role of DAT. Front Neurosci 17:1219441","journal-title":"Front Neurosci"},{"issue":"4","key":"5740_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF03655585","volume":"55","author":"E Fabre","year":"1999","unstructured":"Fabre E et al (1999) Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum. J Physiol Biochem 55(4):325\u2013331","journal-title":"J Physiol Biochem"},{"key":"5740_CR11","doi-asserted-by":"publisher","unstructured":"Lucchesi M et al (2025) Mitochondrial dysfunction in genetic and non-genetic Parkinson\u2019s disease. Int J Mol Sci  26(9). https:\/\/doi.org\/10.3390\/ijms26094451","DOI":"10.3390\/ijms26094451"},{"key":"5740_CR12","doi-asserted-by":"publisher","unstructured":"Brown HJ et al (2025) Imbalanced mitochondrial dynamics in human and mouse PD brains. bioRxiv [Version 1]. https:\/\/doi.org\/10.1101\/2025.01.27.635175","DOI":"10.1101\/2025.01.27.635175"},{"key":"5740_CR13","doi-asserted-by":"publisher","first-page":"947191","DOI":"10.3389\/fnmol.2022.947191","volume":"15","author":"NJ Thorne","year":"2022","unstructured":"Thorne NJ, Tumbarello DA (2022) The relationship of alpha-synuclein to mitochondrial dynamics and quality control. Front Mol Neurosci 15:947191","journal-title":"Front Mol Neurosci"},{"key":"5740_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fnins.2018.00388","volume":"12","author":"M Vicario","year":"2018","unstructured":"Vicario M et al (2018) The close encounter between alpha-synuclein and mitochondria. Front Neurosci 12:388","journal-title":"Front Neurosci"},{"issue":"5","key":"5740_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2174\/1570159X20666220830112408","volume":"21","author":"MA Almikhlafi","year":"2023","unstructured":"Almikhlafi MA et al (2023) Mitochondrial medicine: a promising therapeutic option against various neurodegenerative disorders. Curr Neuropharmacol 21(5):1165\u20131183","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"5740_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1042\/BST20180025","volume":"46","author":"T Briston","year":"2018","unstructured":"Briston T, Hicks AR (2018) Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem Soc Trans 46(4):829\u2013842","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"5740_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.neurol.2014.03.005","volume":"170","author":"V Procaccio","year":"2014","unstructured":"Procaccio V et al (2014) Perspectives of drug-based neuroprotection targeting mitochondria. Rev Neurol (Paris) 170(5):390\u2013400","journal-title":"Rev Neurol (Paris)"},{"key":"5740_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217207","author":"HG Dailah","year":"2022","unstructured":"Dailah HG (2022) Potential of therapeutic small molecules in apoptosis regulation in the treatment of neurodegenerative diseases: an updated review. Molecules. https:\/\/doi.org\/10.3390\/molecules27217207","journal-title":"Molecules"},{"issue":"1","key":"5740_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D et al (2023) The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther 8(1):217","journal-title":"Signal Transduct Target Ther"},{"key":"5740_CR20","doi-asserted-by":"publisher","first-page":"615461","DOI":"10.3389\/fcell.2020.615461","volume":"8","author":"J Prasuhn","year":"2020","unstructured":"Prasuhn J, Davis RL, Kumar KR (2020) Targeting mitochondrial impairment in Parkinson\u2019s disease: challenges and opportunities. Front Cell Dev Biol 8:615461","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"5740_CR21","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.apsb.2022.03.001","volume":"12","author":"J Xu","year":"2022","unstructured":"Xu J et al (2022) Mitochondria targeting drugs for neurodegenerative diseases-design, mechanism and application. Acta Pharm Sin B 12(6):2778\u20132789","journal-title":"Acta Pharm Sin B"},{"key":"5740_CR22","doi-asserted-by":"publisher","first-page":"103993","DOI":"10.1016\/j.mcn.2025.103993","volume":"132","author":"A Chakrabarti","year":"2025","unstructured":"Chakrabarti A, Verma S (2025) Identifying potential genes driving ferroptosis in the substantia nigra and dopaminergic neurons in Parkinson\u2019s disease. Mol Cell Neurosci 132:103993","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"5740_CR23","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG et al (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 3(6):e98","journal-title":"PLoS Genet"},{"issue":"6","key":"5740_CR24","doi-asserted-by":"publisher","first-page":"e0128651","DOI":"10.1371\/journal.pone.0128651","volume":"10","author":"AA Dijkstra","year":"2015","unstructured":"Dijkstra AA et al (2015) Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson\u2019s disease. PLoS ONE 10(6):e0128651","journal-title":"PLoS ONE"},{"issue":"2","key":"5740_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10048-006-0077-6","volume":"8","author":"DC Duke","year":"2007","unstructured":"Duke DC et al (2007) The medial and lateral substantia nigra in Parkinson\u2019s disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 8(2):83\u201394","journal-title":"Neurogenetics"},{"issue":"8","key":"5740_CR26","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s10571-021-01146-8","volume":"42","author":"A Zaccaria","year":"2022","unstructured":"Zaccaria A et al (2022) Multiomic analyses of dopaminergic neurons isolated from human substantia nigra in Parkinson\u2019s disease: a descriptive and exploratory study. Cell Mol Neurobiol 42(8):2805\u20132818","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"5740_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-005-0020-2","volume":"7","author":"LB Moran","year":"2006","unstructured":"Moran LB et al (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson\u2019s disease. Neurogenetics 7(1):1\u201311","journal-title":"Neurogenetics"},{"key":"5740_CR28","unstructured":"Zheng B et al (2010) PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2(52):52ra73"},{"issue":"1","key":"5740_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137B","author":"Y Zhang","year":"2005","unstructured":"Zhang Y et al (2005) Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137B(1):5\u201316","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5740_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.763777","volume":"14","author":"K Tiklova","year":"2021","unstructured":"Tiklova K et al (2021) Disease duration influences gene expression in neuromelanin-positive cells from Parkinson\u2019s disease patients. Front Mol Neurosci 14:763777","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"5740_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF02741387","volume":"16","author":"J Haavik","year":"1998","unstructured":"Haavik J, Toska K (1998) Tyrosine hydroxylase and Parkinson\u2019s disease. Mol Neurobiol 16(3):285\u2013309","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5740_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909","journal-title":"Neuron"},{"issue":"D1","key":"5740_CR33","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S et al (2021) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 49(D1):D1541\u2013D1547","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"5740_CR34","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3","journal-title":"Genome Biol"},{"key":"5740_CR35","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24956.1","author":"L Kolberg","year":"2020","unstructured":"Kolberg L et al (2020) gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.24956.1","journal-title":"F1000Res"},{"issue":"11","key":"5740_CR36","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"key":"5740_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.679568","volume":"15","author":"B Li","year":"2021","unstructured":"Li B et al (2021) Gene4PD: a comprehensive genetic database of Parkinson\u2019s disease. Front Neurosci 15:679568","journal-title":"Front Neurosci"},{"issue":"D1","key":"5740_CR38","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA et al (2022) JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res 50(D1):D165\u2013D173","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"5740_CR39","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G et al (2019) NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res 47(W1):W234\u2013W241","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5740_CR40","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074\u2013D1082","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5740_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.31083\/j.jin2201020","volume":"22","author":"OC Ioghen","year":"2023","unstructured":"Ioghen OC, Ceafalan LC, Popescu BO (2023) SH-SY5Y cell line in vitro models for Parkinson disease research-old practice for new trends. J Integr Neurosci 22(1):20","journal-title":"J Integr Neurosci"},{"issue":"10","key":"5740_CR42","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.1007\/s12035-018-0950-y","volume":"55","author":"R Niranjan","year":"2018","unstructured":"Niranjan R, Mishra KP, Thakur AK (2018) Inhibition of cyclooxygenase-2 (COX-2) initiates autophagy and potentiates MPTP-induced autophagic cell death of human neuroblastoma cells, SH-SY5Y: an inside in the pathology of Parkinson\u2019s disease. Mol Neurobiol 55(10):8038\u20138050","journal-title":"Mol Neurobiol"},{"issue":"17","key":"5740_CR43","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.1111\/jcmm.15608","volume":"24","author":"Y Wu","year":"2020","unstructured":"Wu Y et al (2020) Sepiapterin reductase: characteristics and role in diseases. J Cell Mol Med 24(17):9495\u20139506","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5740_CR44","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.pharmthera.2006.05.014","volume":"112","author":"IA Pikuleva","year":"2006","unstructured":"Pikuleva IA (2006) Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 112(3):761\u2013773","journal-title":"Pharmacol Ther"},{"key":"5740_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroscience.2018.06.011","volume":"385","author":"J Huang","year":"2018","unstructured":"Huang J et al (2018) Mitoferrin-1 is involved in the progression of Alzheimer\u2019s disease through targeting mitochondrial iron metabolism in a Caenorhabditis elegans model of Alzheimer\u2019s disease. Neuroscience 385:90\u2013101","journal-title":"Neuroscience"},{"key":"5740_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuint.2017.03.009","volume":"109","author":"A Long","year":"2017","unstructured":"Long A, Klimova N, Kristian T (2017) Mitochondrial NUDIX hydrolases: a metabolic link between NAD catabolism, GTP and mitochondrial dynamics. Neurochem Int 109:193\u2013201","journal-title":"Neurochem Int"},{"key":"5740_CR47","doi-asserted-by":"publisher","first-page":"628222","DOI":"10.3389\/fcell.2020.628222","volume":"8","author":"SA Mun","year":"2020","unstructured":"Mun SA et al (2020) Structural and biochemical characterization of EFhd1\/swiprosin-2, an actin-binding protein in mitochondria. Front Cell Dev Biol 8:628222","journal-title":"Front Cell Dev Biol"},{"key":"5740_CR48","doi-asserted-by":"publisher","first-page":"626117","DOI":"10.3389\/fcell.2021.626117","volume":"9","author":"R Gilkerson","year":"2021","unstructured":"Gilkerson R, De La Torre P, St Vallier S (2021) Mitochondrial OMA1 and OPA1 as gatekeepers of organellar structure\/function and cellular stress response. Front Cell Dev Biol 9:626117","journal-title":"Front Cell Dev Biol"},{"issue":"10-12","key":"5740_CR49","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1089\/ars.2022.0181","volume":"39","author":"LJ Yan","year":"2023","unstructured":"Yan LJ, Wang Y (2023) Roles of dihydrolipoamide dehydrogenase in health and disease. Antioxid Redox Signal 39(10\u201312):794\u2013806","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"5740_CR50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41467-023-36358-7","volume":"14","author":"MT Rahman","year":"2023","unstructured":"Rahman MT et al (2023) An engineered variant of MECR reductase reveals indispensability of long-chain acyl-ACPs for mitochondrial respiration. Nat Commun 14(1):619","journal-title":"Nat Commun"},{"issue":"Pt 7","key":"5740_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1107\/S2053230X15008559","volume":"71","author":"Z Cheng","year":"2015","unstructured":"Cheng Z et al (2015) Synthesis, purification and crystallographic studies of the C-terminal sterol carrier protein type 2 (SCP-2) domain of human hydroxysteroid dehydrogenase-like protein 2. Acta Crystallogr F Struct Biol Commun 71(Pt 7):901\u2013905","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"7","key":"5740_CR52","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbabio.2016.02.013","volume":"1857","author":"C Wirth","year":"2016","unstructured":"Wirth C et al (2016) Structure and function of mitochondrial complex I. Biochim Biophys Acta 1857(7):902\u2013914","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"5740_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s12276-020-0379-z","volume":"52","author":"JH Lee","year":"2020","unstructured":"Lee JH et al (2020) Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue. Exp Mol Med 52(2):238\u2013252","journal-title":"Exp Mol Med"},{"issue":"51","key":"5740_CR54","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1021\/bi801786y","volume":"47","author":"KT Barglow","year":"2008","unstructured":"Barglow KT et al (2008) Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. Biochemistry 47(51):13514\u201313523","journal-title":"Biochemistry"},{"issue":"5","key":"5740_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cmet.2021.03.003","volume":"33","author":"YP Wang","year":"2021","unstructured":"Wang YP et al (2021) Malic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis. Cell Metab 33(5):1027-1041 e8","journal-title":"Cell Metab"},{"issue":"6","key":"5740_CR56","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1083\/jcb.200705108","volume":"179","author":"K Oishi","year":"2007","unstructured":"Oishi K, Okano H, Sawa H (2007) RMD-1, a novel microtubule-associated protein, functions in chromosome segregation in Caenorhabditis elegans. J Cell Biol 179(6):1149\u20131162","journal-title":"J Cell Biol"},{"issue":"10","key":"5740_CR57","doi-asserted-by":"publisher","first-page":"107740","DOI":"10.1016\/j.jbc.2024.107740","volume":"300","author":"S Boopathy","year":"2024","unstructured":"Boopathy S et al (2024) Identification of SLC25A46 interaction interfaces with mitochondrial membrane fusogens Opa1 and Mfn2. J Biol Chem 300(10):107740","journal-title":"J Biol Chem"},{"issue":"6","key":"5740_CR58","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jmb.2019.01.039","volume":"431","author":"CA Brambley","year":"2019","unstructured":"Brambley CA et al (2019) Characterization of mitochondrial YME1L protease oxidative stress-induced conformational state. J Mol Biol 431(6):1250\u20131266","journal-title":"J Mol Biol"},{"issue":"7","key":"5740_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00018-022-04404-0","volume":"79","author":"MZ Peng","year":"2022","unstructured":"Peng MZ et al (2022) Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism. Cell Mol Life Sci 79(7):375","journal-title":"Cell Mol Life Sci"},{"key":"5740_CR60","doi-asserted-by":"publisher","first-page":"100383","DOI":"10.1016\/j.jbc.2021.100383","volume":"296","author":"L Lysyk","year":"2021","unstructured":"Lysyk L et al (2021) Insights into the catalytic properties of the mitochondrial rhomboid protease PARL. J Biol Chem 296:100383","journal-title":"J Biol Chem"},{"issue":"11","key":"5740_CR61","doi-asserted-by":"publisher","first-page":"10817","DOI":"10.1074\/jbc.M411750200","volume":"280","author":"JR Marszalek","year":"2005","unstructured":"Marszalek JR et al (2005) Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J Biol Chem 280(11):10817\u201310826","journal-title":"J Biol Chem"},{"key":"5740_CR62","doi-asserted-by":"crossref","unstructured":"Princely Abudu  Y et al (2019) NIPSNAP1 and NIPSNAP2 Act as \"Eat Me\" Signals for Mitophagy. Dev Cell 49(4):509\u2013525.e12","DOI":"10.1016\/j.devcel.2019.03.013"},{"issue":"1","key":"5740_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1074\/mcp.RA119.001784","volume":"19","author":"MG Dibley","year":"2020","unstructured":"Dibley MG et al (2020) The mitochondrial acyl-carrier protein interaction network highlights important roles for LYRM family members in complex I and mitoribosome assembly. Mol Cell Proteomics 19(1):65\u201377","journal-title":"Mol Cell Proteomics"},{"issue":"9-10","key":"5740_CR64","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.bbagrm.2011.10.012","volume":"1819","author":"JH Chang","year":"2012","unstructured":"Chang JH, Tong L (2012) Mitochondrial poly(A) polymerase and polyadenylation. Biochim Biophys Acta 1819(9\u201310):992\u2013997","journal-title":"Biochim Biophys Acta"},{"key":"5740_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","volume":"9","author":"A Dumitriu","year":"2016","unstructured":"Dumitriu A et al (2016) Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. BMC Med Genomics 9:5","journal-title":"BMC Med Genomics"},{"issue":"10","key":"5740_CR66","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2013","unstructured":"Masliah E et al (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8(10):1030\u20131038","journal-title":"Epigenetics"},{"issue":"10","key":"5740_CR67","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB et al (2023) DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 3(10):1201\u20131209","journal-title":"Nat Aging"},{"issue":"1","key":"5740_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40035-024-00421-0","volume":"13","author":"E Appleton","year":"2024","unstructured":"Appleton E et al (2024) DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson\u2019s disease. Transl Neurodegener 13(1):31","journal-title":"Transl Neurodegener"},{"issue":"1","key":"5740_CR69","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-023-00374-w","volume":"12","author":"W Paslawski","year":"2023","unstructured":"Paslawski W et al (2023) Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson\u2019s disease. Transl Neurodegener 12(1):42","journal-title":"Transl Neurodegener"},{"issue":"4","key":"5740_CR70","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.brainresbull.2011.11.016","volume":"88","author":"PA Lewis","year":"2012","unstructured":"Lewis PA, Cookson MR (2012) Gene expression in the Parkinson\u2019s disease brain. Brain Res Bull 88(4):302\u2013312","journal-title":"Brain Res Bull"},{"issue":"1","key":"5740_CR71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13041-019-0436-5","volume":"12","author":"J Kelly","year":"2019","unstructured":"Kelly J et al (2019) Gene expression meta-analysis of Parkinson\u2019s disease and its relationship with Alzheimer\u2019s disease. Mol Brain 12(1):16","journal-title":"Mol Brain"},{"issue":"771","key":"5740_CR72","doi-asserted-by":"publisher","first-page":"eabo1997","DOI":"10.1126\/scitranslmed.abo1997","volume":"16","author":"B Zhu","year":"2024","unstructured":"Zhu B et al (2024) Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains. Sci Transl Med 16(771):eabo1997","journal-title":"Sci Transl Med"},{"issue":"5","key":"5740_CR73","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1074\/mcp.RA119.001889","volume":"19","author":"E Griesser","year":"2020","unstructured":"Griesser E et al (2020) Quantitative profiling of the human substantia nigra proteome from laser-capture microdissected FFPE tissue. Mol Cell Proteomics 19(5):839\u2013851","journal-title":"Mol Cell Proteomics"},{"key":"5740_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2148820","volume":"2021","author":"BH Dong","year":"2021","unstructured":"Dong BH et al (2021) Complementary transcriptomic and proteomic analysis in the substantia nigra of Parkinson\u2019s disease. Dis Markers 2021:2148820","journal-title":"Dis Markers"},{"key":"5740_CR75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41531-019-0080-x","volume":"5","author":"KJ Billingsley","year":"2019","unstructured":"Billingsley KJ et al (2019) Mitochondria function associated genes contribute to Parkinson\u2019s disease risk and later age at onset. NPJ Parkinsons Dis 5:8","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5740_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00441-017-2768-8","volume":"373","author":"SB Larsen","year":"2018","unstructured":"Larsen SB, Hanss Z, Kruger R (2018) The genetic architecture of mitochondrial dysfunction in Parkinson\u2019s disease. Cell Tissue Res 373(1):21\u201337","journal-title":"Cell Tissue Res"},{"key":"5740_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.885500","volume":"14","author":"XY Gao","year":"2022","unstructured":"Gao XY et al (2022) Mitochondrial dysfunction in Parkinson\u2019s disease: from mechanistic insights to therapy. Front Aging Neurosci 14:885500","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"5740_CR78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol 24(2):103\u2013116","journal-title":"Exp Neurobiol"},{"issue":"1","key":"5740_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00645-x","volume":"10","author":"S Blumenreich","year":"2024","unstructured":"Blumenreich S et al (2024) Large-scale proteomics analysis of five brain regions from Parkinson\u2019s disease patients with a GBA1 mutation. NPJ Parkinsons Dis 10(1):33","journal-title":"NPJ Parkinsons Dis"},{"key":"5740_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020550","author":"D Wang","year":"2025","unstructured":"Wang D et al (2025) Identification of downregulated MECR gene in Parkinson\u2019s disease through integrated transcriptomic analysis and validation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26020550","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5740_CR81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X et al (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8(1):73","journal-title":"Signal Transduct Target Ther"},{"key":"5740_CR82","first-page":"1690341","volume":"2021","author":"W Quan","year":"2021","unstructured":"Quan W et al (2021) Identification of potential core genes in Parkinson\u2019s disease using bioinformatics analysis. Parkinsons Dis 2021:1690341","journal-title":"Parkinsons Dis"},{"key":"5740_CR83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainres.2007.01.001","volume":"1139","author":"JE Tobin","year":"2007","unstructured":"Tobin JE et al (2007) Sepiapterin reductase expression is increased in Parkinson\u2019s disease brain tissue. Brain Res 1139:42\u201347","journal-title":"Brain Res"},{"issue":"3","key":"5740_CR84","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1074\/jbc.M205601200","volume":"278","author":"AL Perraud","year":"2003","unstructured":"Perraud AL et al (2003) NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase. J Biol Chem 278(3):1794\u20131801","journal-title":"J Biol Chem"},{"issue":"5","key":"5740_CR85","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/cas.15749","volume":"114","author":"K Meng","year":"2023","unstructured":"Meng K et al (2023) EFHD1, a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma. Cancer Sci 114(5):2029\u20132040","journal-title":"Cancer Sci"},{"issue":"1","key":"5740_CR86","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/15548627.2018.1526611","volume":"15","author":"R Kang","year":"2019","unstructured":"Kang R et al (2019) Mitochondrial quality control mediated by PINK1 and PRKN: links to iron metabolism and tumor immunity. Autophagy 15(1):172\u2013173","journal-title":"Autophagy"},{"issue":"11","key":"5740_CR87","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/mds.29577","volume":"38","author":"L Dai","year":"2023","unstructured":"Dai L et al (2023) 27-hydroxycholesterol drives the spread of alpha-synuclein pathology in Parkinson\u2019s disease. Mov Disord 38(11):2005\u20132018","journal-title":"Mov Disord"},{"issue":"10","key":"5740_CR88","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41582-023-00873-4","volume":"19","author":"L Kiani","year":"2023","unstructured":"Kiani L (2023) 27-hydroxycholesterol propagates alpha-synuclein pathology in Parkinson disease. Nat Rev Neurol 19(10):573","journal-title":"Nat Rev Neurol"},{"key":"5740_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.131369","volume":"453","author":"W Duan","year":"2023","unstructured":"Duan W et al (2023) Upregulation of mitochondrial calcium uniporter contributes to paraquat-induced neuropathology linked to Parkinson\u2019s disease via imbalanced OPA1 processing. J Hazard Mater 453:131369","journal-title":"J Hazard Mater"},{"issue":"5","key":"5740_CR90","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ana.25221","volume":"83","author":"M Jonikas","year":"2018","unstructured":"Jonikas M et al (2018) Stem cell modeling of mitochondrial parkinsonism reveals key functions of OPA1. Ann Neurol 83(5):915\u2013925","journal-title":"Ann Neurol"},{"issue":"2","key":"5740_CR91","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85(2):257\u2013273","journal-title":"Neuron"},{"issue":"19","key":"5740_CR92","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/hmg\/ddx262","volume":"26","author":"Z Li","year":"2017","unstructured":"Li Z et al (2017) Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice. Hum Mol Genet 26(19):3776\u20133791","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5740_CR93","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.bbrc.2018.07.117","volume":"503","author":"SJ Choi","year":"2018","unstructured":"Choi SJ et al (2018) Isocitrate dehydrogenase 2 deficiency induces endothelial inflammation via p66sh-mediated mitochondrial oxidative stress. Biochem Biophys Res Commun 503(3):1805\u20131811","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5740_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-510X(90)90056-S","volume":"96","author":"Y Mizuno","year":"1990","unstructured":"Mizuno Y, Suzuki K, Ohta S (1990) Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson\u2019s disease. J Neurol Sci 96(1):49\u201357","journal-title":"J Neurol Sci"},{"issue":"2","key":"5740_CR95","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0197-0186(02)00225-5","volume":"43","author":"GE Gibson","year":"2003","unstructured":"Gibson GE et al (2003) Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson\u2019s disease. Neurochem Int 43(2):129\u2013135","journal-title":"Neurochem Int"},{"issue":"6","key":"5740_CR96","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1046\/j.1471-4159.2003.02263.x","volume":"88","author":"P Klivenyi","year":"2004","unstructured":"Klivenyi P et al (2004) Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem 88(6):1352\u20131360","journal-title":"J Neurochem"},{"issue":"18","key":"5740_CR97","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1093\/nar\/gkv861","volume":"43","author":"M Lapkouski","year":"2015","unstructured":"Lapkouski M, Hallberg BM (2015) Structure of mitochondrial poly(A) RNA polymerase reveals the structural basis for dimerization, ATP selectivity and the SPAX4 disease phenotype. Nucleic Acids Res 43(18):9065\u20139075","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"5740_CR98","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2008.03.005","volume":"44","author":"SR Danielson","year":"2008","unstructured":"Danielson SR, Andersen JK (2008) Oxidative and nitrative protein modifications in Parkinson\u2019s disease. Free Radic Biol Med 44(10):1787\u20131794","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5740_CR99","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1104\/pp.19.00822","volume":"181","author":"A Ivanova","year":"2019","unstructured":"Ivanova A et al (2019) A mitochondrial LYR protein is required for complex I assembly. Plant Physiol 181(4):1632\u20131650","journal-title":"Plant Physiol"},{"issue":"2","key":"5740_CR100","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/cge.14632","volume":"107","author":"NAM Almontashiri","year":"2025","unstructured":"Almontashiri NAM et al (2025) ME2 deficiency is associated with recessive neurodevelopmental disorder. Clin Genet 107(2):201\u2013207","journal-title":"Clin Genet"},{"issue":"1","key":"5740_CR101","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12957-023-03176-6","volume":"21","author":"S Ma","year":"2023","unstructured":"Ma S et al (2023) HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53\/SLC7A11 axis. World J Surg Oncol 21(1):293","journal-title":"World J Surg Oncol"},{"issue":"1","key":"5740_CR102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche M et al (2021) Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects. J Parkinsons Dis 11(1):45\u201360","journal-title":"J Parkinsons Dis"},{"key":"5740_CR103","doi-asserted-by":"publisher","first-page":"1147095","DOI":"10.3389\/fcell.2023.1147095","volume":"11","author":"D Zhou","year":"2023","unstructured":"Zhou D et al (2023) Knock-down of YME1L1 induces mitochondrial dysfunction during early porcine embryonic development. Front Cell Dev Biol 11:1147095","journal-title":"Front Cell Dev Biol"},{"issue":"Pt 4","key":"5740_CR104","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1242\/jcs.093849","volume":"125","author":"SM Jin","year":"2012","unstructured":"Jin SM, Youle RJ (2012) PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 125(Pt 4):795\u2013799","journal-title":"J Cell Sci"},{"key":"5740_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13121717","author":"E Elmorsy","year":"2023","unstructured":"Elmorsy E et al (2023) Differential effects of paraquat, rotenone, and MPTP on cellular bioenergetics of undifferentiated and differentiated human neuroblastoma cells. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13121717","journal-title":"Brain Sci"},{"key":"5740_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042393","author":"D Ashraf","year":"2024","unstructured":"Ashraf D et al (2024) Protein translation in the pathogenesis of Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25042393","journal-title":"Int J Mol Sci"},{"key":"5740_CR107","doi-asserted-by":"publisher","first-page":"971298","DOI":"10.3389\/fgene.2022.971298","volume":"13","author":"SL Schaffner","year":"2022","unstructured":"Schaffner SL, Kobor MS (2022) DNA methylation as a mediator of genetic and environmental influences on Parkinson\u2019s disease susceptibility: impacts of alpha-synuclein, physical activity, and pesticide exposure on the epigenome. Front Genet 13:971298","journal-title":"Front Genet"},{"issue":"10","key":"5740_CR108","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jgg.2016.05.002","volume":"43","author":"L Zhang","year":"2016","unstructured":"Zhang L et al (2016) Targeted methylation sequencing reveals dysregulated Wnt signaling in Parkinson disease. J Genet Genomics 43(10):587\u2013592","journal-title":"J Genet Genomics"},{"key":"5740_CR109","doi-asserted-by":"publisher","first-page":"149689","DOI":"10.1016\/j.brainres.2025.149689","volume":"1862","author":"Z Zhuang","year":"2025","unstructured":"Zhuang Z, Zhang L, Wang Y (2025) USP2 alleviates MPP(+)-induced neuronal injury by stabilizing FOXC1 in SK-N-SH cells. Brain Res 1862:149689","journal-title":"Brain Res"},{"issue":"4","key":"5740_CR110","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11011-025-01585-y","volume":"40","author":"MR Chowdhury","year":"2025","unstructured":"Chowdhury MR et al (2025) Exploring bioactive natural products for treating neurodegenerative diseases: a computational network medicine approach targeting the estrogen signaling pathway in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Metab Brain Dis 40(4):169","journal-title":"Metab Brain Dis"},{"issue":"6","key":"5740_CR111","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pmic.201300342","volume":"14","author":"V Licker","year":"2014","unstructured":"Licker V et al (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson\u2019s disease pathogenesis. Proteomics 14(6):784\u2013794","journal-title":"Proteomics"},{"key":"5740_CR112","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1477-5956-6-8","volume":"6","author":"CJ Werner","year":"2008","unstructured":"Werner CJ et al (2008) Proteome analysis of human substantia nigra in Parkinson\u2019s disease. Proteome Sci 6:8","journal-title":"Proteome Sci"},{"issue":"10","key":"5740_CR113","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00702-022-02530-4","volume":"129","author":"M Wulf","year":"2022","unstructured":"Wulf M et al (2022) Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes. J Neural Transm (Vienna) 129(10):1257\u20131270","journal-title":"J Neural Transm (Vienna)"},{"key":"5740_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031659","author":"W Huang","year":"2024","unstructured":"Huang W et al (2024) The role of protein degradation in estimation postmortem interval and confirmation of cause of death in forensic pathology: a literature review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031659","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5740_CR115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00018-023-04754-3","volume":"80","author":"E Kocsmar","year":"2023","unstructured":"Kocsmar E et al (2023) Proteome alterations in human autopsy tissues in relation to time after death. Cell Mol Life Sci 80(5):117","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"5740_CR116","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1042\/BST20200250","volume":"48","author":"T Tsuboi","year":"2020","unstructured":"Tsuboi T, Leff J, Zid BM (2020) Post-transcriptional control of mitochondrial protein composition in changing environmental conditions. Biochem Soc Trans 48(6):2565\u20132578","journal-title":"Biochem Soc Trans"},{"key":"5740_CR117","doi-asserted-by":"publisher","first-page":"1196466","DOI":"10.3389\/fcell.2023.1196466","volume":"11","author":"A Kadam","year":"2023","unstructured":"Kadam A, Jadiya P, Tomar D (2023) Post-translational modifications and protein quality control of mitochondrial channels and transporters. Front Cell Dev Biol 11:1196466","journal-title":"Front Cell Dev Biol"},{"key":"5740_CR118","doi-asserted-by":"publisher","first-page":"675465","DOI":"10.3389\/fcell.2021.675465","volume":"9","author":"F Wang","year":"2021","unstructured":"Wang F et al (2021) Mitochondrial protein translation: emerging roles and clinical significance in disease. Front Cell Dev Biol 9:675465","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5740_CR119","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","volume":"54","author":"B Pakkenberg","year":"1991","unstructured":"Pakkenberg B et al (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson\u2019s disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 54(1):30\u201333","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"5740_CR120","doi-asserted-by":"publisher","first-page":"e1009822","DOI":"10.1371\/journal.pgen.1009822","volume":"17","author":"R Filograna","year":"2021","unstructured":"Filograna R et al (2021) Mitochondrial dysfunction in adult midbrain dopamine neurons triggers an early immune response. PLoS Genet 17(9):e1009822","journal-title":"PLoS Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05740-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05740-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05740-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:04:12Z","timestamp":1771329852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05740-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5740"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05740-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the author(s) used ChatGPT in order to improve language and readability; the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"446"}}